Halliburton's Profitability Improves, But North America Risks Linger

What happened

A recent Seeking Alpha article highlights Halliburton's improving profitability and international growth, with Latin America up 22% and Europe/Africa up 11% offsetting Middle East/Asia declines, while Q1 2026 net income rose to $461M. The article frames the company as evolving beyond its cyclical reputation through disciplined capital returns and operational efficiency under CEO Jeff Miller. However, the DeepValue Master Report maintains a WAIT rating, noting that the stock already discounts successful margin defense despite a high-single-digit 2026 North America revenue decline guide. Key risks include U.S. frac spreads down 19% year-over-year to 166, disclosed pricing pressure in U.S. Land stimulation, and recent insider selling by multiple executives. While self-help cost saves of ~$100M per quarter provide some cushion, the next 2-3 quarters must show stabilization in U.S. utilization and international award conversion to sustain the bull case.

Implication

Halliburton's self-help actions and international momentum offer a credible path to defend margins and cash returns in a downcycle, but the stock currently prices in successful execution without corresponding evidence. Key checkpoints over the next 6 months include U.S. frac spread stability above 150, no further pricing concessions, and incremental offshore award announcements. The WAIT rating with a base case of $38 suggests limited upside at current levels, while downside risk to $28 exists if pricing deteriorates further. Investors should use any pullback toward the $32 attractive entry level to build positions, but wait for clearer proof of North America stabilization before adding aggressively. Long-term holders can be rewarded if management sustains capital discipline and converts the completion tools order book into revenue, but near-term patience is warranted.

Thesis delta

The Seeking Alpha article reinforces the self-help narrative that the DeepValue report already prices in, but does not alter the fundamental risk-reward balance. Improved Q1 profitability and international growth support the bull case, yet the core waiting stance remains justified because U.S. pricing and utilization data have not turned positive. The thesis shifts from 'hoping for execution' to 'needing confirmation' – evidence of stabilization in the next two quarters is now required to sustain the current valuation.